The significantly higher prevalence of key MAPK pathway alterations, including NF1, ACVR1, and MAP2K1, in H/L EOCRC patients suggests a potential role for MAPK dysregulation in CRC disparities. The gene discussed is ACVR1; the disease is colorectal carcinoma.